SE335857B - - Google Patents

Info

Publication number
SE335857B
SE335857B SE07028/65A SE702865A SE335857B SE 335857 B SE335857 B SE 335857B SE 07028/65 A SE07028/65 A SE 07028/65A SE 702865 A SE702865 A SE 702865A SE 335857 B SE335857 B SE 335857B
Authority
SE
Sweden
Application number
SE07028/65A
Inventor
E Fischer
J Schmutz
F Hunziker
Original Assignee
Wander Ag Dr A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH927660A external-priority patent/CH398620A/de
Priority claimed from CH1354260A external-priority patent/CH404677A/de
Application filed by Wander Ag Dr A filed Critical Wander Ag Dr A
Publication of SE335857B publication Critical patent/SE335857B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D267/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02Seven-membered rings
    • C07D267/08Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/16Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D267/20[b, f]-condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D281/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02Seven-membered rings
    • C07D281/04Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/12Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D281/16[b, f]-condensed
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE07028/65A 1960-08-16 1961-08-16 SE335857B (en:Method)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH927660A CH398620A (de) 1960-08-16 1960-08-16 Verfahren zur Herstellung von Amidinen der Dibenzo (b,e) (1,4)diazepin-Reihe
CH1354260A CH404677A (de) 1960-12-02 1960-12-02 Verfahren zur Herstellung von Amidinen

Publications (1)

Publication Number Publication Date
SE335857B true SE335857B (en:Method) 1971-06-14

Family

ID=25704559

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8266/61A SE321664B (en:Method) 1960-08-16 1961-08-16
SE07028/65A SE335857B (en:Method) 1960-08-16 1961-08-16

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE8266/61A SE321664B (en:Method) 1960-08-16 1961-08-16

Country Status (6)

Country Link
DE (1) DE1620703B2 (en:Method)
ES (1) ES269845A1 (en:Method)
FR (1) FR1402M (en:Method)
GB (1) GB980853A (en:Method)
NL (1) NL6413698A (en:Method)
SE (2) SE321664B (en:Method)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115568A (en) 1974-11-26 1978-09-19 Lilly Industries Limited Thieno[3,2-b]-[1,5]benzodiazepines
GB1587128A (en) * 1977-04-07 1981-04-01 Hexachimie Benzothiazepine derivatives
WO1997000252A1 (en) * 1995-06-16 1997-01-03 Warner-Lambert Company Tricyclic inhibitors of protein farnesyltransferase
JP2009516705A (ja) * 2005-11-18 2009-04-23 アストラゼネカ・アクチエボラーグ 塩の形態
PL2307389T3 (pl) * 2008-06-20 2013-05-31 Astrazeneca Ab Pochodne dibenzotiazepiny i ich zastosowanie

Also Published As

Publication number Publication date
DE1620703A1 (de) 1970-06-18
SE321664B (en:Method) 1970-03-16
GB980853A (en) 1965-01-20
ES269845A1 (es) 1962-04-01
NL6413698A (en:Method) 1965-01-25
DE1620703B2 (de) 1976-11-25
FR1402M (fr) 1962-08-17

Similar Documents

Publication Publication Date Title
BE604833R (en:Method)
BE601704A (en:Method)
FR180269A (en:Method)
FR1572952A (en:Method)
FR1229351A (en:Method)
BE605264A (en:Method)
BE607368A (en:Method)
SE335857B (en:Method)
BE644128A (en:Method)
BE607545A (en:Method)
BE607526A (en:Method)
BE604663A (en:Method)
BE599188A (en:Method)
NL265918A (en:Method)
NL262046A (en:Method)
NL260899A (en:Method)
NL247559A (en:Method)
NL126326C (en:Method)
BE604775A (en:Method)
BE611467A (en:Method)
BE585555A (en:Method)
BE605950A (en:Method)
BE605928A (en:Method)
BE605708A (en:Method)
BE605226A (en:Method)